Home/Arsenal Biosciences/Gift Ngarmchamnanrith, MD
GN

Gift Ngarmchamnanrith, MD

Chief Medical Officer

Arsenal Biosciences

Therapeutic Areas

Arsenal Biosciences Pipeline

DrugIndicationPhase
AB-3028Metastatic Castration-Resistant Prostate Cancer (mCRPC)IND-Enabling
AB-7000Undisclosed Solid TumorIND-Enabling
AB-4000 Series (with BMS)Solid TumorsDiscovery/Preclinical